BLCM

Bellicum Pharmaceuticals, Inc.
BLCM

Overview Fund Activity
Delisted

BLCM was delisted on the 1st of June, 2023.

Back to rankings

94 hedge funds and large institutions have $85.1M invested in Bellicum Pharmaceuticals, Inc. in 2019 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 29 increasing their positions, 25 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
94
Holders Change
+2
Holders Change %
+2.17%
% of All Funds
2.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
29
Reduced
25
Closed
11
Calls
$85K
Puts
$95K
Net Calls
-$10K
Net Calls Change
-$14K

Top Buyers

1
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
+$3.58M
2
NAMA
Nikko Asset Management Americas
New York
+$3.58M
3
Renaissance Technologies
Renaissance Technologies
New York
+$1.8M
4
AIM
ARK Investment Management
Florida
+$1.17M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$926K

Top Sellers

1
FCM
Farallon Capital Management
California
-$2.92M
2
WA
Wasatch Advisors
Utah
-$2.84M
3
Millennium Management
Millennium Management
New York
-$943K
4
SIM
Spark Investment Management
New York
-$227K
5
BlackRock
BlackRock
New York
-$206K
Name Holding Trade Value Shares
Change 		Shares
Change %
CLOS
101
Compagnie Lombard Odier SCmA
Switzerland
– -$4K -150 Closed
AIC
102
Ameritas Investment Company
Nebraska
– -$1K -44 Closed
1 2 3 4
5